EMEA (Europe, Middle East and Africa) Rheumatoid Arthritis Drugs Market Report 2017

August 2017 | 114 pages | ID: E0A2C0BD7D3EN
QYResearch

Abstracts

In this report, the EMEA Rheumatoid Arthritis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Rheumatoid Arthritis Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rheumatoid Arthritis Drugs market competition by top manufacturers/players, with Rheumatoid Arthritis Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Amgen
• BMS
• Johnson & Johnson
• Pfizer
• F. Hoffmann-La Roche
• Ablynx
• Alder BioPharmaceuticals
• Antares Medical Services
• Astellas Pharma
• AstraZeneca
• Boehringer Ingelheim

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Oral
• Parenteral
• Topical

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rheumatoid Arthritis Drugs for each application, including

• NSAIDs
• DMARDs
• Corticosteroids
• Analgesics
• Others

Contents

EMEA (Europe, Middle East and Africa) Rheumatoid Arthritis Drugs Market Report 2017

1 RHEUMATOID ARTHRITIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Rheumatoid Arthritis Drugs
1.2 Classification of Rheumatoid Arthritis Drugs
  1.2.1 EMEA Rheumatoid Arthritis Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Rheumatoid Arthritis Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Parenteral
  1.2.5 Topical
1.3 EMEA Rheumatoid Arthritis Drugs Market by Application/End Users
  1.3.1 EMEA Rheumatoid Arthritis Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 NSAIDs
  1.3.3 DMARDs
  1.3.4 Corticosteroids
  1.3.5 Analgesics
  1.3.6 Others
1.4 EMEA Rheumatoid Arthritis Drugs Market by Region
  1.4.1 EMEA Rheumatoid Arthritis Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Rheumatoid Arthritis Drugs (2012-2022)
  1.5.1 EMEA Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Rheumatoid Arthritis Drugs Revenue and Growth Rate (2012-2022)

2 EMEA RHEUMATOID ARTHRITIS DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Rheumatoid Arthritis Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Rheumatoid Arthritis Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Rheumatoid Arthritis Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Rheumatoid Arthritis Drugs Sale Price by Players (2012-2017)
2.2 EMEA Rheumatoid Arthritis Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Rheumatoid Arthritis Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Rheumatoid Arthritis Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Rheumatoid Arthritis Drugs Sale Price by Type (2012-2017)
2.3 EMEA Rheumatoid Arthritis Drugs (Volume) by Application
2.4 EMEA Rheumatoid Arthritis Drugs (Volume and Value) by Region
  2.4.1 EMEA Rheumatoid Arthritis Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Rheumatoid Arthritis Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Rheumatoid Arthritis Drugs Sales Price by Region (2012-2017)

3 EUROPE RHEUMATOID ARTHRITIS DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Rheumatoid Arthritis Drugs Sales and Value (2012-2017)
  3.1.1 Europe Rheumatoid Arthritis Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Rheumatoid Arthritis Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Rheumatoid Arthritis Drugs Sales and Market Share by Type
3.3 Europe Rheumatoid Arthritis Drugs Sales and Market Share by Application
3.4 Europe Rheumatoid Arthritis Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Rheumatoid Arthritis Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Rheumatoid Arthritis Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RHEUMATOID ARTHRITIS DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Rheumatoid Arthritis Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Rheumatoid Arthritis Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Rheumatoid Arthritis Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Rheumatoid Arthritis Drugs Sales and Market Share by Type
4.3 Middle East Rheumatoid Arthritis Drugs Sales and Market Share by Application
4.4 Middle East Rheumatoid Arthritis Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Rheumatoid Arthritis Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Rheumatoid Arthritis Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)

5 AFRICA RHEUMATOID ARTHRITIS DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Rheumatoid Arthritis Drugs Sales and Value (2012-2017)
  5.1.1 Africa Rheumatoid Arthritis Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Rheumatoid Arthritis Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Rheumatoid Arthritis Drugs Sales and Market Share by Type
5.3 Africa Rheumatoid Arthritis Drugs Sales and Market Share by Application
5.4 Africa Rheumatoid Arthritis Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Rheumatoid Arthritis Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Rheumatoid Arthritis Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Rheumatoid Arthritis Drugs Sales and Growth Rate (2012-2017)

6 EMEA RHEUMATOID ARTHRITIS DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 BMS
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 BMS Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 F. Hoffmann-La Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ablynx
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ablynx Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Alder BioPharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Antares Medical Services
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Antares Medical Services Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Astellas Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Rheumatoid Arthritis Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Astellas Pharma Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 AstraZeneca
6.12 Boehringer Ingelheim

7 RHEUMATOID ARTHRITIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Rheumatoid Arthritis Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rheumatoid Arthritis Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rheumatoid Arthritis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rheumatoid Arthritis Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RHEUMATOID ARTHRITIS DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Rheumatoid Arthritis Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Rheumatoid Arthritis Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Rheumatoid Arthritis Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Rheumatoid Arthritis Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Rheumatoid Arthritis Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Rheumatoid Arthritis Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rheumatoid Arthritis Drugs
Figure EMEA Rheumatoid Arthritis Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Rheumatoid Arthritis Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Parenteral Product Picture
Figure Topical Product Picture
Figure EMEA Rheumatoid Arthritis Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Rheumatoid Arthritis Drugs by Application in 2016
Figure NSAIDs Examples
Figure DMARDs Examples
Figure Corticosteroids Examples
Figure Analgesics Examples
Figure Others Examples
Figure EMEA Rheumatoid Arthritis Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Rheumatoid Arthritis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Rheumatoid Arthritis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Rheumatoid Arthritis Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Rheumatoid Arthritis Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Rheumatoid Arthritis Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales Share by Players (2012-2017)
Figure 2016 Rheumatoid Arthritis Drugs Sales Share by Players
Figure 2017 Rheumatoid Arthritis Drugs Sales Share by Players
Figure EMEA Rheumatoid Arthritis Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Rheumatoid Arthritis Drugs Revenue Share by Players
Table 2017 EMEA Rheumatoid Arthritis Drugs Revenue Share by Players
Table EMEA Rheumatoid Arthritis Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Rheumatoid Arthritis Drugs by Type (2012-2017)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share by Type (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rheumatoid Arthritis Drugs by Type in 2016
Table EMEA Rheumatoid Arthritis Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Rheumatoid Arthritis Drugs by Application (2012-2017)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share by Application in 2016
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Rheumatoid Arthritis Drugs by Region (2012-2017)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share in 2016
Table EMEA Rheumatoid Arthritis Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Rheumatoid Arthritis Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Rheumatoid Arthritis Drugs by Region (2012-2017)
Figure EMEA Rheumatoid Arthritis Drugs Revenue Market Share Regions in 2016
Table EMEA Rheumatoid Arthritis Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Revenue and Growth Rate (2012-2017)
Table Europe Rheumatoid Arthritis Drugs Sales (K Units) by Type (2012-2017)
Table Europe Rheumatoid Arthritis Drugs Market Share by Type (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Market Share by Type in 2016
Table Europe Rheumatoid Arthritis Drugs Sales (K Units) by Application (2012-2017)
Table Europe Rheumatoid Arthritis Drugs Market Share by Application (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Market Share by Application in 2016
Table Europe Rheumatoid Arthritis Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Rheumatoid Arthritis Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Sales Market Share by Countries in 2016
Table Europe Rheumatoid Arthritis Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Rheumatoid Arthritis Drugs Revenue Market Share by Countries in 2016
Figure Germany Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Market Share by Type (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Market Share by Type (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Market Share by Applications (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Sales Market Share by Application in 2016
Table Middle East Rheumatoid Arthritis Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Rheumatoid Arthritis Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Rheumatoid Arthritis Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Sales (K Units) by Type (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Sales Market Share by Type (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share by Type (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share by Type in 2016
Table Africa Rheumatoid Arthritis Drugs Sales (K Units) by Application (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Sales Market Share by Application (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share by Application (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share by Countries in 2016
Table Africa Rheumatoid Arthritis Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Rheumatoid Arthritis Drugs Revenue Market Share by Countries in 2016
Figure South Africa Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Table AbbVie Rheumatoid Arthritis Drugs Basic Information List
Table AbbVie Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure AbbVie Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Rheumatoid Arthritis Drugs Basic Information List
Table Amgen Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table BMS Rheumatoid Arthritis Drugs Basic Information List
Table BMS Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure BMS Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure BMS Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Rheumatoid Arthritis Drugs Basic Information List
Table Johnson & Johnson Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Rheumatoid Arthritis Drugs Basic Information List
Table Pfizer Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Basic Information List
Table F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Ablynx Rheumatoid Arthritis Drugs Basic Information List
Table Ablynx Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ablynx Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Ablynx Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Ablynx Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Basic Information List
Table Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Alder BioPharmaceuticals Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Antares Medical Services Rheumatoid Arthritis Drugs Basic Information List
Table Antares Medical Services Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Antares Medical Services Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Antares Medical Services Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Antares Medical Services Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Rheumatoid Arthritis Drugs Basic Information List
Table Astellas Pharma Rheumatoid Arthritis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Rheumatoid Arthritis Drugs Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Rheumatoid Arthritis Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Rheumatoid Arthritis Drugs Basic Information List
Table Boehringer Ingelheim Rheumatoid Arthritis Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rheumatoid Arthritis Drugs
Figure Manufacturing Process Analysis of Rheumatoid Arthritis Drugs
Figure Rheumatoid Arthritis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Rheumatoid Arthritis Drugs Major Manufacturers in 2016
Table Major Buyers of Rheumatoid Arthritis Drugs
Table Distributors/Traders List
Figure EMEA Rheumatoid Arthritis Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Rheumatoid Arthritis Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Rheumatoid Arthritis Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Rheumatoid Arthritis Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Rheumatoid Arthritis Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Rheumatoid Arthritis Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Rheumatoid Arthritis Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Rheumatoid Arthritis Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Rheumatoid Arthritis Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Rheumatoid Arthritis Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources